Autori: Jassem Jacek
Naslov | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article) |
Autori | Jassem Jacek ... Andric Zoran G ... (broj koautora 19) |
Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882 |
Projekat | Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis (Article) |
Autori | Cufer Tanja Ciuleanu Tudor E Berzinec Peter Galffy Gabriela Jakopovic Marko Jassem Jacek Jovanovic Dragana D Mihaylova Zhasmina Ostoros Gyula Thallinger Christiane Zemanova Milada Zielinski Christoph |
Info | ONCOLOGIST, (2020), vol. 25 br. 3, str. E598-E601 |
Projekat | AstraZeneca |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Delays in diagnosis and treatment of breast cancer: a multinational analysis (Article) |
Autori | Jassem Jacek Ozmen Vahit Bacanu Florin Drobniene Monika Eglitis Janis Lakshmaiah Kuntegowdanahalli C Kahan Zsuzsanna Mardiak Jozef Pienkowski Tadeusz Semiglazova Tatiana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Vrbanec Damir Zaborek Piotr |
Info | EUROPEAN JOURNAL OF PUBLIC HEALTH, (2014), vol. 24 br. 5, str. 761-767 |
Projekat | Roche Poland |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey (Meeting Abstract) |
Autori | Jassem Jacek Bacanu Florin Eglitis Janis Mardiak Jozef Pienkowski Tadeusz Kahan Zsuzsanna Ozmen Vahit Drobniene Monika Vrbanec Damir Semiglazova Tatyana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Zaborek Piotr |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2012), vol. 30 br. 15, Suppl. S, str. - |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey (Meeting Abstract) |
Autori | Jassem Jacek Ozmen Vahit Bacanu Florin Drobniene Monika Eglitis Janis Kahan Zsuzsanna Lakshmaiah Kuntegowdanahalli C Mardiak Jozef Pienkowski Tadeusz Semiglazova Tatiana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Vrbanec Damir Zaborek Piotr |
Info | CANCER RESEARCH, (2012), vol. 72 br. , Suppl. 24, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial (Article) |
Autori | Jassem Jacek Pienkowski Tadeusz Pluzanska Anna Jelic Svetislav S Gorbunova Vera Berzins Juris Nagykalnai Thomas Biganzoli Laura Aloe Alessandra Astier Ludovic Munier Stephane |
Info | ONKOLOGIE, (2009), vol. 32 br. 8-9, str. 468-472 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | A randomized phase III multicenter trial of doxorubicin and paclitaxel (AT) versus fluorouracil-doxorubicin-cyclophosphamide (FAC) as first-line therapy metastatic breast cancer (MBC): long-term efficacy and external review of results. (Meeting Abstract) |
Autori | Jassem Jacek Pluzanska Anna Pienkowski Tadeusz Gershanovitch MA Uziely B Jelic Svetislav S Biganzoli Laura Gwyther SJ Aloe Alessandra Astier Ludovic Munier Stephane |
Info | BREAST CANCER RESEARCH AND TREATMENT, (2004), vol. 88 br. , Suppl. Suppl. 1, str. S198-S198 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial (Article) |
Autori | Jassem Jacek Pienkowski Tadeusz Pluzanska Anna Jelic Svetislav B Gorbunova Vera Mrsic-Krmpotic Zrinka Berzins Juris Nagykalnai Thomas Wigler N Renard J Munier Stephane Weil C |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2001), vol. 19 br. 6, str. 1707-1715 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|